We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
A long-term study in Nature Communications confirmed the efficacy of optimized AAV9 gene therapy for spinal muscular atrophy. Learn about safety and treatment prospects.
